Model
Edge
CNS Pharmaceuticals Inc.
CNSP
Filing type
8-K
Filing date
Mar 1, 2026
Updated
Mar 3, 2026 ยท 2:03 AM
Copy reference
Filing
8-K
Changes in Board, Management or Compensation
Exhibits
EX-10.1
EMPLOYMENT AGREEMENT BETWEEN LYNNE KELLEY AND CNS PHARMACEUTICALS, INC.
EX-10.2
SEPARATION AND SEVERANCE AGREEMENT BETWEEN SANDRA SILBERMAN AND CNS PHARMACEUTICALS, INC.